Location History:
- Yokohama, JP (1994)
- Osaka, JP (1998)
Company Filing History:
Years Active: 1994-1998
Title: The Innovations of Masaki Sunami: Pioneering Transdermal Drug Delivery
Introduction: Masaki Sunami, an esteemed inventor based in Yokohama, Japan, has made significant contributions to the field of transdermal drug administration. With a total of two patents to his name, Sunami has focused on creating innovative medicated plaster technologies that enhance the efficacy of drug delivery systems.
Latest Patents: Sunami's recent patents include groundbreaking advancements in medicated plasters. His first patent discusses a medicated plaster containing basic physiologically active agents and/or components that ensure effective drug release through a flexible support with a pressure-sensitive adhesive layer. This innovative design features a pressure-sensitive adhesive layer that has an exposed surface with a pH of 7 or higher, incorporating crucial elements that facilitate drug delivery.
Additionally, his second patent details a preparation for transdermal drug administration, featuring a flexible backing layer and a pressure-sensitive adhesive layer that contains a local anesthetic in the ideal proportion of 40-65 weight%. The unique ratio of undissolved to dissolved local anesthetic ensures superior self-adhesiveness without leaving residual adhesive on the skin after removal, while allowing for an immediate anesthetic effect. This rapid release mechanism enhances Sunami’s preparation's clinical application potential, showcasing his remarkable innovations in drug delivery.
Career Highlights: Masaki Sunami works for Nitto Denko Corporation, a company renowned for its commitment to research and development in advanced materials and technologies. His role as an inventor within this prestigious organization has been vital in driving forward the development of novel therapeutic applications, positioning him as a pivotal figure in the field of biomedical engineering.
Collaborations: Throughout his career, Sunami has collaborated with notable colleagues, including Akihito Yamanaka and Takashi Kinoshita. These partnerships have fostered a collaborative environment that encourages innovation and the exchange of ideas, ultimately leading to the advancement of their collective work in the pharmaceutical sector.
Conclusion: Masaki Sunami's continued dedication to developing innovative drug delivery systems reflects his commitment to enhancing patient care through science and technology. With two pivotal patents under his belt, Sunami is not only a talented inventor but also a key player in shaping the future of transdermal drug administration. His work promises to make a significant impact on the medical community and improve the quality of life for many patients.